Skip to main content

Advertisement

SpringerLink
Log in

Techno-borne Organs: Medical, Legal, and Policy Concerns

  • Published:
Journal of the Knowledge Economy Aims and scope Submit manuscript

Abstract

Techno-borne organs (TBO) are promising organ-repair strategies in a broad spectrum of terminal diseases. Their benefit/risk ratio is debated in medical, legal, and religious circles. An attempt was made to elucidate risks and advantages in implication of the TBO. Findings suggest that the TBO, created from either autologous, syngenic or isogenic cells, is an auspicious frontier that eliminates risks associated to the traditional transplantation of the donor organs: incompatibility, transplant failure, long waiting lists, health insurance constraints, fraud, conspiracy, and increasing number of lawsuits. On the other hand, the TBO emerge with specific disadvantages. Medical risks are associated with the cell-scaffold interactions, TBO’s sterility and the potential to replicate in vivo. New parametric standards are necessary to determine the TBO transplant’s success or failure. Regulatory issues include the Coordinating Committee’s current federal oversight limited for the commercial products. Rejoining of the NSF and NIH to the Coordination Committee would help expand the regulations to assess scientific novelty and upstream. Potential legal issues may include TBO patentability (matter, process, nonobviousness, novelty), patient’s substantive due process rights of bodily integrity and TBO ownership under the 14th Amendment, advance directives for autopsy of a TBO carrier, and the extent of publishing an invention - a shared property between the scientist and the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Drager, N., & Mendoza, M. R. (2002). WTO agreements and public health: a joint study by the WHO and the WTO secretariat. Geneva: WHO, World Trade Organization. https://www.wto.org/english/res_e/booksp_e/who_wto_e.pdf.

  • 35 U.S. Code § 101.

  • 42 USC 282 (b)(16) section 402(b)(16).

  • ACMG Applauds Supreme Court Decision on Gene Patents (2013). www.acmg.net/docs/GenePatientsDecision.pdf.

  • AIPA, Public Law 106–113, 113 Stat. 1501 (1999).

  • Akpolat, T., & Ozturk, M. (1998). Commerce in renal transplantation. Transplant Proceedings, 30, 710–711.

    Article  Google Scholar 

  • Al-Wakeel, J., Mitwall, A. H., Tarif, N., et al. (2000). Living unrelated renal transplantation: outcome and issues. Saudi Journal of Kidney Disease & Transplantation, 11, 553–558.

    Google Scholar 

  • Association for Molecular Pathology v. Myriad Genetics, 569 U.S. 12–398 (2013).

  • Badylak, S. (2015). Grow your own. McGowan Institute for Regenerative Medicine, University of Pittsburgh and UPMC.

  • Bentley, T. S., & Hanson, S. G. (2014). 2014 U.S. organ and tissue transplant costs estimates and discussions. Milliman Research Report.

  • Bilski v.Kappos, 130 S. Ct. 3218 – 2010.

  • Boettiger, S., & Bennett, A. B. (2006). Bahy-Dole: if we knew then what we know now. Nature Publishing Group. www.pipra.org.

  • Bradley, F. J. (2014). Life engineered with expanded genetic code. San Diego Union Tribune.

  • Brenner v. Manson, 383 US 519–1966.

  • Brotherton v. Cleveland, 923 F. 2d 477 - Court of Appeals, 6th Circuit 1991.

  • Brown v. Delaware Val. Trans. Program, 615 A. 2d 1379 - Pa: Superior Court 1992.

  • Carey v. New England Organ Bank, 446 Mass. 270 - Mass: Supreme Judicial Court 2006.

  • Colakoglu, M., Yenicesu, M., Akpolat, T., et al. (1998). Nonrelated living-donor kidney transplantation: medical and ethical aspects. Nephron, 79, 447–451.

    Article  Google Scholar 

  • Colavito v. New York Organ Donor Network, Inc., 438 F. 3d 214 -Court of Appeals, 2nd Circuit 2006.

  • Colavito v. NY Organ Donor, 860 NE 2d 713 - NY: Court of Appeals 2006.

  • Curran v. Bosze, 566 NE 2d 1319 - Ill: Supreme Court 1990.

  • Delaney v. Signature Health Care Foundation, 376 S.W.3d 55 (2012).

  • Delaware Valley Transplant Program v. Coye, 678 F. Supp. 479 - Dist. Court, D. New Jersey 1988.

  • Dexter v. Kirschner, 984 F. 2d 979 - Court of Appeals, 9th Circuit 1992.

  • Diamond v. Chakrabarty, 447 U.S. 303 (1980).

  • DiMartini, Crone, C., Fireman, M., et al. (2009). Psychiatric aspects of organ transplantation In critical care. Critical Care Clinics, 24(4), 949–x.

  • Doe v. Group Hospitalization & Medical Services, 3 F. 3d 80 (1993).

  • Edgardo, E. G., Petrenko, A. Y., Balabam, C. L., et al. (2011). Organ preservation: current concepts and new strategies for the next decade. Transfusion Medicine and Hemotherapy, 38(2), 125–142.

    Article  Google Scholar 

  • Ellis by Ellis v. Patterson, 859 F. 2d 52 - Court of Appeals, 8th Circuit 1988.

  • Endy, D. (2005). Foundations for Engineering Biology. A, C, T, and G refer to the four essential nucleotide base pairs that make up DNA: adenine, cytosine, thymine, and guanine. Nature, 438(7067), 449–453.

  • Engle, D. (2001). Psychosocial aspects of the organ transplant experience: what has been established and what we need for the future. Journal of Clinical Psychology, 57(4), 521–549.

    Article  Google Scholar 

  • First self-replicating synthetic cacterial cell. Press Release, March 20, 2010. http://www.jcvi.org/cms/press.

  • Frishberg, Y., Feinstein, S., & Drukker, A. (1998). Living unrelated (commercial) renal transplantation in children. Journal of the American Society of Nephrology, 9, 1100–1103.

    Google Scholar 

  • Ghods, A. J., & Nasrollahzadeh, D. (2005). Transplant tourism and the Iranian model of renal transplantation program: ethical considerations. Experimental & Clinical Transplantology, 3, 351–354.

    Google Scholar 

  • Griffith, M., Hakim, M. A., Shimmura, S. M., et al. (2002). Artificial human corneas: scaffolds for transplantation and host regeneration. Cornea, 21(p), S54–S61.

    Article  Google Scholar 

  • id § 102.

  • id § 103.

  • id § 112.

  • In re Guardianship of Pescinski, 226 NW 2d 180 - Wis: Supreme Court 1975.

  • In re Richardson, 284 So. 2d 185 - La: Court of Appeals, 4th Circuit 1973.

  • In re TACP, 609 So. 2d 588 - Fla: Supreme Court 1992.

  • In re Wands, 858 F.2d at 737, 8 USPQ2d at 1404 (Fed. Cir. 1988).

  • Inston, N. G., Gill, D., Al-Hakim, A., & Ready, A. R. (2005). Living paid organ transplantation results in unacceptably high recipient morbidity and mortality. Transplant Proceedings, 37, 560–562.

    Article  Google Scholar 

  • Irvine v. Regents of the University of Cal, 57 Cal.Rptr.3d 500 (2007).

  • Ivanovski, N., Popov, Z., Cakalaroski, K., et al. (2005). Living-unrelated (paid) renal transplantation—ten years later. Transplant Proceedings, 37, 563–564.

    Article  Google Scholar 

  • Kahan, D. (2000). Gentle nudges vs. hard shoves: solving the sticky norms problem. University of Chicago Law Review, 67, 607–645.

  • Kennedy, S. E., Shen, Y., Charlesworth, J. A., et al. (2005). Outcome of overseas commercial kidney transplantation: an Australian perspective. Medical Journal of Australia, 182, 224–227.

    Google Scholar 

  • Kraemer, J. D., Gostin, L. O., & Lawrence, O. (2012). The limits of government regulation of science. Georgetown Law, 776, 1047–1049.

  • Kucuk, M., Sever, M. S., Turkmen, A., et al. (2005). Demographic analysis and outcome features in a transplant outpatient clinic. Transplant Proceedings, 37, 743–746.

    Article  Google Scholar 

  • Lee, C. Y., & Mangino, M. J. (2009). Preservation methods for kidney and liver. Organogenesis, 5, 105–112.

    Article  Google Scholar 

  • Lin, S. (2003). Nephrology in China: a great mission and momentous challenge. Kidney International Supply, 63, 108–110.

    Article  Google Scholar 

  • Little v. Little, 576 SW 2d 493 - Tex: Court of Civil Appeals, 4th Dist. 1979.

  • Lyon v. US, 843 F. Supp. 531 - Dist. Court, Minnesota 1994.

  • McAnulty, J. (2010). Hypothermic organ preservation by static cold storage methods: current status and a view to the future. Cryobiology, 60(3 suppl), S13–S19.

    Article  Google Scholar 

  • Meusberger v. Palmer, 900 F. 2d 1280 - Court of Appeals, 8th Circuit 1990.

  • Miller by Miller v. Whitburn, 10 F. 3d 1315 - Court of Appeals, 7th Circuit 1993.

  • Mineral Separation v. Hyde, 242 U.S. 261, 270 (1916).

  • Minhua, J., & Yingguang, Z. (2005). Beijing mulls new law on transplants of death-row inmates organs. Caijing.

  • Moore v. Regents of University of California, 793 P. 2d 479 - Cal: Supreme Court 1990.

  • Morad, Z., & Lim, T. O. (2000). Outcome of overseas kidney transplantation in Malaysia. Transplant Proceedings, 32, 1485–1486.

    Article  Google Scholar 

  • Newman v. Sathyavaglswaran, 287 F. 3d 786 - Court of Appeals, 9th Circuit 2002.

  • Office of Science and Technology Policy [OSTP] (1986). Coordinated Framework for Regulation of Biotechnology. Executive Office of President, Office of Science and Technology Policy; 51 FR 23302.

  • Paradise, J., & Fitzpatrick, E. (2014). Synthetic biology: Does re-writing nature require re-writing regulation? 88 Penn State Law Review, 117, 1.

  • Parker v. Flook, 437 U.S. 584, 589, 198 USPQ 193, 197 (1978).

  • People v. Eulo, 63 NY 2d 341 - NY: Court of Appeals 1984.

  • Perry v. Saint Francis Hosp. & Medical Center, 886 F. Supp. 1551 - Dist. Court, D. Kansas 1995.

  • Pittman by Pope v. Secretary, Florida DHRS, 998 F. 2d 887 - Court of Appeals, 11th Circuit 1993.

  • Rai, A. K., & Eisenberg, R. S. (2003). Bayh-Dole reform and the progress of biomedicine. Law and Contemporary Problems, 66, 289–314.

    Google Scholar 

  • Rizvi AH, Naqvi AS, Zafar NM, Ahmed E (2009). Regulated compensated donation in Pakistan and Iran. Current Opinion in Organ Transplantation; 14(2):124–128

  • Salgado v. Kirschner, 878 P. 2d 659 - Ariz: Supreme Court 1994.

  • Schact, W. H. (2000). Patent ownership and Federal research and development: A discussion on the Bayh-Dole Act and the Stevenson-Wydler Act. A CRS report for Congress.

  • Scheper-Hughes, N. (2008). Prime numbers: organs without borders. Foreign Policy, 2005, 29–31.

    Google Scholar 

  • Semenza, G. L. (2000). Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. Journal of Clinical Investigation, 106, 809–811.

    Article  Google Scholar 

  • Sever, M. S., Kazancioglu, R., Yildiz, A., et al. (2001). Outcome of living unrelated (commercial) renal transplantation. Kidney International, 60, 1477–1483.

    Article  Google Scholar 

  • Shimazono, Y. (2007). The state of the international organ trade: a provisional picture based on integration of available information. Bulletin of the World Health Organization, 85(12), 901–908.

    Article  Google Scholar 

  • Simkins v. NevadaCare, Inc., 229 F. 3d 729 - Court of Appeals, 9th Circuit 2000.

  • State v. Shaffer, 574 P. 2d 205 - Kan: Supreme Court 1977.

  • Stepp, D. L. (1999). The history of FDA regulation of biotechnology in the twentieth century. Food and Drug Law, 46, 1–116.

    Google Scholar 

  • Strey, C. W., Gestrich, J., Beckhaus, T., et al. (2010). Hypoxia and reoxygenation of primary human hepatocytes induce proteome changes of glucose metabolism, oxidative protection and peroxisomal function. International Journal of Molecular Medicine, 26, 577–584.

    Article  Google Scholar 

  • Strunk v. Strunk, 445 SW 2d 145 - Ky: Court of Appeals 1969.

  • Tan, T.-E., Peh, G. S. L., George, B. L., et al. (2014). A cost-minimization analysis of tissue-engineered constructs for corneal endothelial transplantation. PLoS ONE, 9(6), e100563.

    Article  Google Scholar 

  • Tennessee Valley Authority v. Hill, 437 U.S., at 194, 98 S.Ct., at 2302 (1978).

  • Tianjin, K. C. (2005). A transplant “mecca” that attracts patients from 19 Asian countries. Chusonilbo, January 30. http://www.chosunonline.com/article/20050130000046.

  • Toffenetti, J. L. (2014). The fundamentals of life sciences law. Drugs, Devices, and Biotechnology; 2nd Ed. AHLA.

  • 35 U.S.C. 112 (a). 2164.01 Test of Enablement [R-08.2012]

  • Wheat v. Mass, 994 F. 2d 273 - Court of Appeals, 5th Circuit 1993.

  • WHO Report. (2012). Keeping kidneys. Bulletin of the World Health Organization, 90(1), 713–792.

    Google Scholar 

  • Williams, D. (2004). Benefit and risk in tissue engineering. Materials Today, 7(5), 24–29.

    Article  Google Scholar 

  • Williams, J. (2013). Heart-transplant survivors realize ‘the miracle of life’ after surgery. Orlando Sentinel.

  • Williams v. Hofmann, 223 NW 2d 844 - Wis: Supreme Court 1974.

  • Wota v. Blue Cross and Blue Shield, 831 P. 2d 1307 - Colo: Supreme Court 1992.

  • Wozniak, C. A., Waggoner, A. F., & Reilly, S. (2012). An Introduction to Agricultural Biotechnology Regulation in the U.S. Biopesticides and Pollution Prevention Division, Office of Pesticide Programs. The U.S. Environmental Protection Agency.

Download references

Author information

Authors and Affiliations

  1. New European Surgical Academy, Atlanta, GA, USA

    Naira R. Matevosyan

  2. Seton Hall University School of Law, Newark, NJ, USA

    Naira R. Matevosyan

Authors
  1. Naira R. Matevosyan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naira R. Matevosyan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matevosyan, N.R. Techno-borne Organs: Medical, Legal, and Policy Concerns. J Knowl Econ 9, 544–560 (2018). https://doi.org/10.1007/s13132-015-0346-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13132-015-0346-4

Keywords

Search

Navigation